Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Ideal Power
IPWR
$81.5M
| $75.8K | ﹤0.01% |
+14,146
| New | +$72K |
|
|
LENZ
3702
LENZ Therapeutics
LENZ
$167M
| $75.3K | ﹤0.01% |
13,256
-1,671
| -11% | -$13.5K |
|
|
SY
3703
So-Young International
SY
$267M
| $74.4K | ﹤0.01% |
50,277
-6,980
| -12% | -$16.8K |
|
3704
Health Catalyst
HCAT
$128M
| $74.2K | ﹤0.01% |
37,278
-80,852
| -68% | -$117K |
|
3705
Gossamer Bio
GOSS
$87.9M
| $72.8K | ﹤0.01% |
442,268
-22,700
| -5% | -$6.34K |
|
3706
Cardlytics
CDLX
$22M
| $70.1K | ﹤0.01% |
15,617
-1,584
| -9% | -$11.8K |
|
3707
DHI Group
DHX
$187M
| $68.6K | ﹤0.01% |
18,489
-2,104
| -10% | -$6.95K |
|
3708
eHealth
EHTH
$31.3M
| $68K | ﹤0.01% |
45,607
-23,890
| -34% | -$40K |
|
3709
AN2 Therapeutics
ANTX
$226M
| $67K | ﹤0.01% |
+13,839
| New | +$59.5K |
|
3710
Stereotaxis
STXS
$130M
| $66.3K | ﹤0.01% |
38,570
+12,152
| +46% | +$22.8K |
|
3711
Nautilus Biotechnolgy
NAUT
$118M
| $65.8K | ﹤0.01% |
+35,200
| New | +$92.9K |
|
3712
Acumen Pharmaceuticals
ABOS
$229M
| $65.7K | ﹤0.01% |
+24,588
| New | +$60.7K |
|
|
CNTN
3713
Canton Strategic Holdings
CNTN
$178M
| $65.1K | ﹤0.01% |
+23,075
| New | +$72.9K |
|
3714
Comtech Telecommunications
CMTL
$47M
| $64.7K | ﹤0.01% |
30,796
+17,645
| +134% | +$67.9K |
|
3715
Kaltura
KLTR
$226M
| $64.6K | ﹤0.01% |
49,704
+4,631
| +10% | +$6.28K |
|
3716
NN Inc
NNBR
$309M
| $62.8K | ﹤0.01% |
17,490
-1,583
| -8% | -$3.94K |
|
|
OKUR
3717
OnKure Therapeutics
OKUR
$138M
| $62.2K | ﹤0.01% |
+13,636
| New | +$58.5K |
|
3718
Unicycive Therapeutics
UNCY
$140M
| $61.9K | ﹤0.01% |
+13,207
| New | +$97.4K |
|
3719
Veritone
VERI
$92M
| $61.5K | ﹤0.01% |
+44,866
| New | +$85.7K |
|
|
SRG
3720
Seritage Growth Properties
SRG
$115M
| $60.8K | ﹤0.01% |
23,106
-2,585
| -10% | -$6.8K |
|
3721
ADC Therapeutics
ADCT
$166M
| $59.7K | ﹤0.01% |
55,762
+14,132
| +34% | +$41.2K |
|
3722
Five Point Holdings
FPH
$365M
| $59.6K | ﹤0.01% |
+11,314
| New | +$56.7K |
|
3723
XTI Aerospace
XTIA
$40.4M
| $58.9K | ﹤0.01% |
32,534
+964
| +3% | +$1.85K |
|
|
BZAI
3724
Blaize Holdings
BZAI
$66.6M
| $57.8K | ﹤0.01% |
41,880
+728
| +2% | +$1.28K |
|
3725
Hyperfine
HYPR
$87.2M
| $57.4K | ﹤0.01% |
+42,535
| New | +$61.4K |
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.